MedTrace Logo

HIV Clinic-Based Intervention to Improve ART Adherence and Prevent HIV Transmission

NCT02044484 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2794

Last updated 2025-03-20

No results posted yet for this study

Summary

This research, co-sponsored by the Centers for Disease Control and Prevention and the National Institute of Mental health, is conducted at six HIV clinics in the U.S. The research examines the effect of a clinic-based multi-component intervention delivered to HIV patients when they attend clinic for primary care. The study tests the hypothesis that the intervention will improve the viral load status of patients and improve attendance for HIV primary care.

Conditions

Interventions

BEHAVIORAL

Multi-component intervention

The computer-based intervention (CBI) is offered to patients whose viral load exceeds 1000 copies/mL at enrollment. Counseling is offered to patients whose viral load does not drop 1-log after the first CBI or remains above 200 copies/mL after completing two CBIs. The behavioral screener will be conducted of all patients at primary care visits. The patient completes the screener before seeing the provider. Responses are given to their provider who can use it in clinical care of the patient. At primary care visits, all patients are given a palm card containing 1 of 15 empowering messages before they leave the clinic. Messages cover three domains: adhering to antiretroviral therapy, regular care, and safer sex.

Sponsors & Collaborators

Principal Investigators

  • Thomas P Giordano, MD · Baylor College of Medicine

  • Margaret Sullivan, MD · Boston University

  • Matthew Golden, MD · University of Washington

  • Edward Cachay, MD · University of California, San Diego

  • Michael J Mugavero, MD · University of Alabama at Birmingham

  • Allan E Rodriguez, MD · University of Miami

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-06-30
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02044484 on ClinicalTrials.gov